Scot Harper
Chief Tech/Sci/R&D Officer bij RADIOPHARM THERANOSTICS LIMITED
Profiel
Scot L.
Harper is currently the Senior Vice President-Clinical Operations at Radiopharm Theranostics Ltd.
Previously, he worked as the Vice President-Clinical Operations at Endocyte, Inc. from 2013 to 2016.
Harper received his undergraduate degree from DePauw University, his graduate degree from the University of South Alabama, and his doctorate from The Indiana University School of Medicine.
Actieve functies van Scot Harper
| Bedrijven | Functie | Begin |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 01-12-2021 |
Eerdere bekende functies van Scot Harper
| Bedrijven | Functie | Einde |
|---|---|---|
| ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 28-10-2016 |
Opleiding van Scot Harper
| DePauw University | Undergraduate Degree |
| University of South Alabama | Graduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Bedrijven in privébezit | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
